FDA Adverse Event Malfunction Summary report: N

ALINITY I TOTAL B-HCG REAGENT KIT

MDR report key: 25260167 · Received May 22, 2026

Report

Report Number
3005094123-2026-00247
Event Type
Malfunction
Date Received
May 22, 2026
Date of Event
May 11, 2026
Report Date
May 22, 2026
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION
Product Code
DHA
UDI-DI
00380740121518
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SECTION A PATIENT INFORMATION: REFER TO SECTION B5 FOR COMPLETE PATIENT INFORMATION. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 07P51-30, THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 7P51-21 / 31, WITH 510K/PMA/BLA NUMBER K170317. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Description of Event or Problem · 0

THE CUSTOMER REPORTED A FALSE POSITIVE ALINITY I TOTAL -HCG RESULT GENERATED BY THE ALINITY I PROCESSING MODULE FOR A 38-YEAR-OLD FEMALE PATIENT. THE SAMPLE WAS REPEATED, AND NEGATIVE RESULTS WERE OBTAINED. THE FOLLOWING DATA WERE PROVIDED: SID (B)(6): INITIAL RESULT ((B)(6)) = 60 IU/L (POSITIVE). REPEAT RESULT ((B)(6)) = <3 IU/L, <3 IU/L, <3 IU/L (ALL NEGATIVE). THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
551504 ALINITY I TOTAL B-HCG REAGENT KIT SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN DHA ABBOTT IRELAND DIAGNOSTICS DIVISION 84201UD00 00380740121518

Patients

Seq Age Sex Outcome Treatment
1